MEK inhibitor

BOSTON — September 28, 2026 Verastem Oncology announced the publication in Gynecologic Oncology of two-year follow-up data from the...

NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...

NEW YORK – August 26, 2026 Immuneering Corporation (Nasdaq: IMRX) highlighted its continued focus on first-line metastatic pancreatic cancer...

Stevenage, United Kingdom, December 1, 2025 NRG Therapeutics has announced the appointment of Dr. Paul Thompson as Chief Development...

Miami, Florida, November 28, 2025 Pasithea Therapeutics has announced the pricing of a $60 million public offering ,strengthening its...

Wilmington, Delaware, November 2025 AstraZeneca has announced that Koselugo (selumetinib) has received expanded FDA approval in the United States...

MIAMI, November 4, 2025: Pasithea Therapeutics Corp. has announced the activation of a new clinical trial site at the...